STOCK TITAN

Genelux Corp Financials

GNLX
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Genelux Corp (GNLX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GNLX FY2025

Genelux is still a capital-funded development-stage company, with operating burn overwhelming its almost nonexistent revenue base.

From FY2023 through FY2025, financing inflows totaled about $82.4M while operating cash outflow totaled about $66.8M. That cash support explains why liquidity and equity recovered from FY2022’s distressed position even though revenue stayed effectively immaterial; balance-sheet repair came from fundraising, not self-funded operations.

The losses are cash losses, not mainly accounting noise: FY2025 net loss of $32.1M was close to operating cash burn of $25.3M. Depreciation was only $244K, and free cash flow was -$26.4M, so the burn reflects paying today’s research and administrative costs rather than a capex-heavy buildout.

The cleaner balance sheet also came with a much larger share count, rising from 9.1M to 38.1M shares between FY2022 and FY2025, which shows external capital has been the main fuel rather than revenue-funded growth. Liquidity is better than in FY2022, but cash of $5.3M remains small against FY2025 operating burn of $25.3M, leaving the company reliant on outside funding to sustain the current cost base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Genelux Corp's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress
-15.42

Genelux Corp scores -15.42, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($132.7M) relative to total liabilities ($7.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/7

Genelux Corp passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.79x

For every $1 of reported earnings, Genelux Corp generates $0.79 in operating cash flow (-$25.3M OCF vs -$32.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$8K
YoY+0.0%

Genelux Corp generated $8K in revenue in fiscal year 2025. This represents an increase of 0.0% from the prior year.

EBITDA
-$33.0M
YoY-4.8%

Genelux Corp's EBITDA was -$33.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.8% from the prior year.

Net Income
-$32.1M
YoY-7.6%

Genelux Corp reported -$32.1M in net income in fiscal year 2025. This represents a decrease of 7.6% from the prior year.

EPS (Diluted)
$-0.86
YoY+9.5%

Genelux Corp earned $-0.86 per diluted share (EPS) in fiscal year 2025. This represents an increase of 9.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$26.4M
YoY-22.0%

Genelux Corp generated -$26.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 22.0% from the prior year.

Cash & Debt
$5.3M
YoY-37.7%

Genelux Corp held $5.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
38M
YoY+9.8%

Genelux Corp had 38M shares outstanding in fiscal year 2025. This represents an increase of 9.8% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
-415175.0%
YoY-18975.0pp

Genelux Corp's operating margin was -415175.0% in fiscal year 2025, reflecting core business profitability. This is down 18975.0 percentage points from the prior year.

Net Margin
-401812.5%
YoY-28450.0pp

Genelux Corp's net profit margin was -401812.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 28450.0 percentage points from the prior year.

Return on Equity
-278.5%
YoY-164.8pp

Genelux Corp's ROE was -278.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 164.8 percentage points from the prior year.

Capital Allocation

R&D Spending
$19.9M
YoY+4.5%

Genelux Corp invested $19.9M in research and development in fiscal year 2025. This represents an increase of 4.5% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$1.1M
YoY+188.2%

Genelux Corp invested $1.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 188.2% from the prior year.

GNLX Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $5.8M N/A $4.7M-0.4% $4.8M+1.3% $4.7M N/A $4.1M-8.3% $4.4M
SG&A Expenses $3.4M N/A $3.5M+13.8% $3.0M-2.7% $3.1M N/A $2.9M+16.8% $2.5M
Operating Income -$9.2M N/A -$8.2M-5.2% -$7.8M+0.3% -$7.8M N/A -$6.9M-0.7% -$6.9M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$8.9M N/A -$8.0M-6.6% -$7.5M+0.5% -$7.5M N/A -$6.5M+1.7% -$6.6M
EPS (Diluted) $-0.20 N/A $-0.21-5.0% $-0.20+4.8% $-0.21 N/A $-0.19+13.6% $-0.22

GNLX Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $32.4M+70.1% $19.0M-23.9% $25.0M-22.5% $32.2M-17.3% $39.0M+12.3% $34.7M-13.8% $40.3M-10.9% $45.2M
Current Assets $26.8M+76.8% $15.1M-29.8% $21.6M-26.3% $29.2M-18.7% $35.9M+13.9% $31.5M-12.3% $36.0M+3.1% $34.9M
Cash & Equivalents $9.3M+73.9% $5.3M+13.7% $4.7M-28.3% $6.5M-59.6% $16.2M+89.2% $8.6M+40.4% $6.1M-22.3% $7.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $9.5M+26.3% $7.5M+17.0% $6.4M-23.4% $8.3M-8.6% $9.1M+8.3% $8.4M+17.6% $7.2M-4.4% $7.5M
Current Liabilities $7.3M+16.8% $6.2M+21.4% $5.1M-26.6% $7.0M-9.1% $7.7M+11.4% $6.9M+24.3% $5.6M-4.3% $5.8M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $22.9M+98.6% $11.5M-37.9% $18.6M-22.2% $23.9M-19.9% $29.8M+13.6% $26.3M-20.6% $33.1M-12.2% $37.7M
Retained Earnings -$292.5M-3.1% -$283.5M-3.4% -$274.3M-3.0% -$266.3M-2.9% -$258.9M-3.0% -$251.4M-3.7% -$242.4M-2.7% -$235.9M

GNLX Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$6.1M+2.3% -$6.2M+5.7% -$6.6M+6.9% -$7.1M-29.9% -$5.4M-26.3% -$4.3M+25.2% -$5.7M+15.8% -$6.8M
Capital Expenditures $921K+111.2% $436K-15.7% $517K+349.6% $115K+283.3% $30K-68.8% $96K+255.6% $27K-88.2% $228K
Free Cash Flow -$7.0M-5.2% -$6.6M+6.4% -$7.1M+1.1% -$7.2M-31.3% -$5.5M-24.3% -$4.4M+23.8% -$5.8M+18.1% -$7.1M
Investing Cash Flow -$8.5M-230.1% $6.6M+39.0% $4.7M+277.9% -$2.7M-175.6% $3.5M-47.4% $6.7M+67.2% $4.0M+123.3% -$17.1M
Financing Cash Flow $18.5M+6616.7% $276K $0-100.0% $52K-99.5% $9.6M+10413.2% $91K $0-100.0% $27.7M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

GNLX Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity -39.0% N/A -42.8%-11.6pp -31.2%-6.1pp -25.1% N/A -19.5%-2.1pp -17.5%
Return on Assets -27.6% N/A -31.8%-8.7pp -23.1%-3.9pp -19.2% N/A -16.1%-1.5pp -14.6%
Current Ratio 3.68+1.2 2.43-1.8 4.20+0.0 4.18-0.5 4.67+0.1 4.57-1.9 6.47+0.5 6.01
Debt-to-Equity 0.41-0.2 0.65+0.3 0.340.0 0.35+0.0 0.31-0.0 0.32+0.1 0.22+0.0 0.20
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Genelux Corp (GNLX) reported $8K in total revenue for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Genelux Corp (GNLX) revenue grew by 0% year-over-year, from $8K to $8K in fiscal year 2025.

No, Genelux Corp (GNLX) reported a net income of -$32.1M in fiscal year 2025, with a net profit margin of -401812.5%.

Genelux Corp (GNLX) reported diluted earnings per share of $-0.86 for fiscal year 2025. This represents a 9.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Genelux Corp (GNLX) had EBITDA of -$33.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Genelux Corp (GNLX) had an operating margin of -415175.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Genelux Corp (GNLX) had a net profit margin of -401812.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Genelux Corp (GNLX) has a return on equity of -278.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Genelux Corp (GNLX) generated -$26.4M in free cash flow during fiscal year 2025. This represents a -22.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Genelux Corp (GNLX) generated -$25.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Genelux Corp (GNLX) had $19.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Genelux Corp (GNLX) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Genelux Corp (GNLX) invested $19.9M in research and development during fiscal year 2025.

Genelux Corp (GNLX) had 38M shares outstanding as of fiscal year 2025.

Genelux Corp (GNLX) had a current ratio of 2.43 as of fiscal year 2025, which is generally considered healthy.

Genelux Corp (GNLX) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Genelux Corp (GNLX) had a return on assets of -168.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Genelux Corp (GNLX) had $5.3M in cash against an annual operating cash burn of $25.3M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Genelux Corp (GNLX) has an Altman Z-Score of -15.42, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Genelux Corp (GNLX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Genelux Corp (GNLX) has an earnings quality ratio of 0.79x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top